Humanin gene expression in fibroblast of Down syndrome subjects.


Journal

International journal of medical sciences
ISSN: 1449-1907
Titre abrégé: Int J Med Sci
Pays: Australia
ID NLM: 101213954

Informations de publication

Date de publication:
2020
Historique:
received: 08 08 2019
accepted: 12 12 2019
entrez: 6 3 2020
pubmed: 7 3 2020
medline: 5 1 2021
Statut: epublish

Résumé

Down syndrome (DS) is characterized by trisomy of chromosome 21 and peculiar phenotype. Humanin (HN) is a mitochondrial short 24-residue polypeptide whit anti-apoptotic and neuroprotective effects. In this study we evaluated HN protein expression and HN mRNA levels in cultured fibroblasts from DS patients and normal controls. Our results obtained by immunocytochemistry, western-blot and qRT-PCR analysis show a significant HN up-regulation in DS patients. These results confirm previous studies and suggest a role for HN may in the DS phenotype.

Identifiants

pubmed: 32132866
doi: 10.7150/ijms.39145
pii: ijmsv17p0320
pmc: PMC7053358
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

320-324

Informations de copyright

© The author(s).

Déclaration de conflit d'intérêts

Competing Interests: The authors have declared that no competing interest exists.

Références

Neurosci Bull. 2014 Dec;30(6):923-935
pubmed: 25391447
Alzheimers Dement. 2015 Jun;11(6):700-9
pubmed: 25510383
Int J Med Sci. 2018 Jan 1;15(1):31-35
pubmed: 29333085
J Gerontol A Biol Sci Med Sci. 2019 Apr 23;74(5):600-607
pubmed: 29955888
Curr Drug Deliv. 2019;16(3):226-232
pubmed: 30381074
Hum Cell. 2018 Apr;31(2):179-181
pubmed: 29502158
Am J Physiol Heart Circ Physiol. 2018 Nov 1;315(5):H1127-H1136
pubmed: 30004252
Dev Disabil Res Rev. 2013;18(1):51-67
pubmed: 23949829
Ann Rheum Dis. 2005 Jun;64(6):816-23
pubmed: 15567815
Rev Invest Clin. 2005 Sep-Oct;57(5):691-4
pubmed: 16419464
Eur J Med Genet. 2016 Aug;59(8):392-5
pubmed: 27343989
Sci Rep. 2018 Sep 21;8(1):14212
pubmed: 30242290
J Alzheimers Dis. 2015;46(1):145-50
pubmed: 25720405

Auteurs

Michele Salemi (M)

Oasi Research Institute-IRCCS, Troina (EN), Italy.

Federico Ridolfo (F)

UOSD of Clinical Pathology, ASUR Marche -AV2, Hospital of Senigallia, Senigallia, Italy.

Maria Grazia Salluzzo (MG)

Oasi Research Institute-IRCCS, Troina (EN), Italy.

Rossella Cannarrella (R)

Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.

Mariaconcetta Giambirtone (M)

Oasi Research Institute-IRCCS, Troina (EN), Italy.

Salvatore Caniglia (S)

Oasi Research Institute-IRCCS, Troina (EN), Italy.

Cataldo Tirolo (C)

Oasi Research Institute-IRCCS, Troina (EN), Italy.

Raffaele Ferri (R)

Oasi Research Institute-IRCCS, Troina (EN), Italy.

Corrado Romano (C)

Oasi Research Institute-IRCCS, Troina (EN), Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH